HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Coronary Serum Exosomes Derived from Patients with Myocardial Ischemia Regulate Angiogenesis through the miR-939-mediated Nitric Oxide Signaling Pathway.

Abstract
Rationale: Angiogenesis is a crucial step towards tissue repair and regeneration after ischemia. The role of circulating exosomes in angiogenic signal transduction has not been well elucidated. Thus, this study aims to investigate the effects of coronary serum exosomes from patients with myocardial ischemia on angiogenesis and to elucidate the underlying mechanisms. Methods and Results: The patients were enrolled according to the inclusion and exclusion criteria. Coronary blood was obtained from the angiography catheter. Serum exosomes were purified and characterized by their specific morphology and surface markers. In vitro analysis showed that compared to exosomes from healthy controls (con-Exo), exosomes from patients with myocardial ischemia (isc-Exo) enhanced endothelial cell proliferation, migration and tube formation. In a mouse hind-limb ischemia model, blood perfusion and histological staining demonstrated that isc-Exo significantly promoted blood flow recovery and enhanced neovascularization compared to con-Exo. Further, we revealed that cardiomyocytes, but not cardiac fibroblasts or endothelial cells, were initiated to release exosomes under ischemic stress; cardiomyocytes might be the source of bioactive exosomes in coronary serum. In addition, microarray analysis indicated that miR-939-5p was significantly down-regulated in isc-Exo. By knockdown and overexpression analyses, we found that miR-939-5p regulated angiogenesis by targeting iNOS. miR-939-5p inhibited both iNOS's expression and its activity, attenuated endothelial NO production, and eventually impaired angiogenesis. Conclusions: Exosomes derived from patients with myocardial ischemia promote angiogenesis via the miR-939-iNOS-NO pathway. Our study highlights that coronary serum exosomes serve as an important angiogenic messenger in patients suffering from myocardial ischemia.
AuthorsHao Li, Yiteng Liao, Lei Gao, Tao Zhuang, Zheyong Huang, Hongming Zhu, Junbo Ge
JournalTheranostics (Theranostics) Vol. 8 Issue 8 Pg. 2079-2093 ( 2018) ISSN: 1838-7640 [Electronic] Australia
PMID29721064 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • MIRN939 microRNA, human
  • MicroRNAs
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
Topics
  • Aged
  • Animals
  • Base Sequence
  • Cell Hypoxia
  • Cell Movement
  • Cell Proliferation
  • Coronary Circulation
  • Down-Regulation (genetics)
  • Exosomes (metabolism)
  • Female
  • Hindlimb (blood supply, pathology)
  • Human Umbilical Vein Endothelial Cells (metabolism)
  • Humans
  • Ischemia (blood, pathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • MicroRNAs (genetics, metabolism)
  • Middle Aged
  • Myocardial Ischemia (blood, genetics)
  • Myocytes, Cardiac (metabolism, pathology)
  • NIH 3T3 Cells
  • Neovascularization, Physiologic
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase Type II (metabolism)
  • Rats
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: